A pair of studies presented at the 2024 American Society of Hematology (ASH) Annual Meeting & Exposition highlight continuing ...

Patients with multiple myeloma are living longer, thanks to a host of new immunotherapies and targeted drugs. But there is ...

Two researchers from Huntsman Cancer Institute at the University of Utah (the U) have discovered a gene variant found in high ...

Stephen D. Nimer, M.D., has been awarded the American Society of Hematology’s (ASH) Mentor Award for 2024. As director ...

Research at the annual meeting of the American Society of Hematology evaluated patient and caregiver perspectives on gene ...

Preliminary data demonstrate that CTX112™ has the potential to provide meaningful clinical benefit with a well-tolerated safety profile using a ...

Therapeutically relevant levels of Factor VIII (FVIII) activity sustained in ongoing nonhuman primate (NHP) study through ...

By Karen Roman ReAlta Life Sciences said it is presenting new data at the American Society of Hematology (ASH) Annual Meeting ...

Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing next-generation programmed T cell therapies, announces an oral presentation and three poster ...

Alison Moskowitz, Associate Attending at Memorial Sloan Kettering Cancer Center and lead investigator of the phase 1 study, presented new investigational combination data in an oral presentation at ...

DelveInsight's Hematology Market Insights report provides the current and forecast market analysis, individual leading ...